Gil Roth05.30.13
Patricia Kitchen has been named vice president, R&D at Tapemark. Ms. Kitchen has 20 years of pharma experience, ranging from protein and API development to deformulation and formulation expertise, to operational scale-up and commercialization. Most recently she was executive director of Global Operational Excellence for Actavis, Inc. (formerly Watson Pharmaceuticals). Her prior experience includes leadership roles within Bayer Healthcare and Bristol-Myers Squibb. A Tapemark statement noted, "Her reputation as an expert in transdermal patches will be an excellent addition as Tapemark continues to grow its business in the generic patch market."
Andy Rensink, president and chief operating officer of Tapemark, commented, “Patricia is a great fit for Tapemark and we are delighted to add her to our leadership team. Her expertise and her reputation in transdermal development are well-suited for Tapemark’s expansion into full vertical integration, as we add formulation, blending, and coating to our existing superior converting and packaging capabilities.”
Andy Rensink, president and chief operating officer of Tapemark, commented, “Patricia is a great fit for Tapemark and we are delighted to add her to our leadership team. Her expertise and her reputation in transdermal development are well-suited for Tapemark’s expansion into full vertical integration, as we add formulation, blending, and coating to our existing superior converting and packaging capabilities.”